Recordati SpA (RER1.MU)
- Bloomberg
KKR, TPG Express Interest in Italian Drugmaker Recordati
(Bloomberg) -- KKR & Co. and TPG Inc. are among suitors to have expressed initial interest in Italian drugmaker Recordati SpA, people familiar with the matter said.Most Read from BloombergWhat to Know About the Deadly Flesh-Eating Bacteria Spreading in JapanFlesh-Eating Bacteria That Can Kill in Two Days Spreads in JapanThese Are the World’s Most Expensive Cities for Expats in 2024Hedge Funds’ Secret Weapon to Fight the SEC Lives in TexasEx-Trump Adviser Urges Him to Cut Ties With China, Restart
- Reuters
UPDATE 1-CVC explores options for Italy's Recordati, Bloomberg News reports
CVC Capital Partners is exploring options for its controlling stake in Italian pharmaceutical group Recordati SpA, Bloomberg News reported on Tuesday, citing people familiar with the matter. CVC and Recordati did not immediately respond to a Reuters request for comments. A CVC-led consortium of investment funds had agreed to buy 51.8% of Recordati in a deal worth about 3 billion euros in 2018.
